The effect of i.v. enalaprilat in chronically treated hypertensive patients during cardiac surgery

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 8, 1998, Pages 929-935

  Schuetz, W H ^a,b   Lindner, K H ^a   Georgieff, M ^a   Mueller, S ^a   Oertel, F ^a   Radermacher, P ^a   Gauss, A ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Angiotensin converting enzyme inhibitors; Arginine vasopressin; Catecholamines; Heart surgery; Hypertension

Indexed keywords

ADRENALIN; ARGIPRESSIN; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ENALAPRILAT; NORADRENALIN; RENIN; URAPIDIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; HEART SURGERY; HEMODYNAMICS; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0031720223     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05352.x     Document Type: Article

References (30)

1. Estafanous FG, Tarazi RC. Systemic arterial hypertension associated with cardiac surgery. Am J Cardiol 1980: 46: 685-694.
2. Leslie JB. Incidence and aetiology of perioperative hypertension. Acta Anaesthesiol Scand 1993: 37 (Suppl 99): 5-9.
3. Reves JC, Karp RB, Buttner EE, Tosone S, Smith LR, Samuelson PN et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 1982: 66: 49-55.
4. Kennedy DJ, Butterworth JF. Endocrine function during and after cardiopulmonary bypass: recent observations. J Clin Endocrinol Metab 1994: 78: 997-1002.
5. Reid IA. Interactions between ANC II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992: 262: E763-E778.
6. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993: 45: 205-251.
7. Strauss R, Gavras I, Vlahakos D, Gavras H. Enalaprilat in hypertensive emergencies. J Clin Pharmacol 1986: 26: 39-43.
8. Paller MS, Linas SL. Role of angiotensin II, α-adrenergic system, and arginine vasopressin on arterial pressure in rat. Am J Physiol 1984: 246: H25-H30.
9. Kumagai H, Suzuki H, Ichikawa M, Matsumura Y, Jimbo M, Ryuzaki M et al. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits. Circ Res 1993: 72: 1255-1265.
10. De Paula RB, Plavnik FL, Rodrigues CIS, De A Rocha Neves F, Kohlmann O Jr, Ribeiro AB et al. Contribution of vasopressin to orthostatic blood pressure maintenance in essential hypertension. Am J Hypertens 1993: 6: 794-798.
11. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993: 153: 154-183.
12. Prengel AW, Lindner KH, Ensinger H, Grünert A. Plasma catecholamine concentrations after successful resuscitation in patients. Crit Care Med 1992: 20: 609-614.
13. Glick SM, Kagan A. Radioimmunoassay of arginine vasopressin. In: Jaffe BM, Behrmann HR, eds. Methods of hormone radioimmunoassays. New York: Academic Press, 1979: 126-139.
14. Higaki J, Ogihara T, Imai N, Kumahara Y, Houtani S, Nishiura M et al. A new sensitive direct radioimmunoassay for human plasma renin and its clinical application. J Lab Clin Med 1984: 104: 947-954.
15. DeMarco T, Daly PA, Liu M, Kayser S, Parmley WW, Chatterjee K. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol 1987: 9: 1131-1138.
16. Kubo SH, Cody RJ, Laragh JH, Prida XE, Steven AA, Yuan Z et al. Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure. Am J Cardiol 1985: 55: 122-126.
17. Gonzales-Fernandez RA, Altieri PI, Jimenez R, Lastra J, Melendez JR, Martinez-Toro JA et al. Effects of enalaprilat on hemodynamics and ventricular activation duration in hypertensive patients with left ventricular hypertrophy. Am J Hypertens 1993: 6: 570-578.
18. Hirschl MM, Binder M, Bur A, Herkner H, Brunner M, Müllner M et al. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises. Arch Intern Med 1995: 155: 2217-2223.
19. MacFadyen RJ, Lees KR, Reid JL. Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure. Br Heart J 1993: 69: 293-297.
20. Monos E, Cox RH, Peterson LH. Direct effect of physiological doses of arginine vasopressin on the arterial wall in vivo. Am J Physiol 1978: 234: H167-H172.
21. Hawkins S. Forsling M, Treasure T, Aveling W. Changes in pressor hormone concentrations in association with coronary artery surgery. Br J Anaesth 1986: 58: 1267-1272.
22. Knight A, Forsling M, Treasure T, Aveling W, Loh L, Sturridge MF. Changes in plasma vasopressin concentration in association with coronary artery surgery or thymectomy. Br J Anaesth 1986: 58: 1273-1277.
23. Roberts AJ, Niarchos AP, Sabramanian VA, Abel RM, Herman SD, Sealey JE et al. Systemic hypertension associated with coronary artery bypass surgery. J Thorac Cardiovasc Surg 1977: 74: 846-859.
24. Taylor KM, Morton IJ, Brown JJ, Bain WH, Caves PK. Hypertension and the renin-angiotensin system following open-heart surgery. J Thorac Cardiovasc Surg 1977: 74: 840-845.
25. Philbin DM, Levine FH, Kono K, Coggins CH, Moss J, Slater EE et al. Attenuation of the stress response of cardiopulmonary bypass by the addition of pulsatile flow. Circulation 1981: 64: 808-812.
26. Parviainen I, Rantala A, Ruokonen E, Tenhunen J, Takala JC. Angiotensin converting enzyme inhibition has no effect on blood pressure and splanchnic perfusion after cardiac surgery. J Crit Care (in press).
27. Weinstein GS, Zabetakis PM, Clavel A, Franzone A, Agrawal M, Gleim G et al. The renin-angiotensin system is not responsible for hypertension following coronary artery bypass grafting. Ann Thorac Surg 1987: 43: 74-77.
28. Colson P, Grolleau D, Chaptal PA, Ribstein J, Mimran A, Roquefeuil B. Effect of preoperative renin-angiotensin system blockade on hypertension following coronary surgery. Chest 1988: 93: 1156-1158.
29. Boldt J, Schindler E, Härter K, Görlach G, Hempelmann G. Influence of intravenous administration of angiotensin-converting enzyme inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients. Anesth Analg 1995: 80: 480-485.
30. Murphy JD, Vaughan RS, Rosen M. Intravenous enalaprilat and autonomic reflexes. Anaesthesia 1989: 44: 816-821.